Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM)

CUSIP: 867781403

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
2,850,581
Total 13F shares
2,748,847
Share change
+1,440,361
Total reported value
$745,736
Price per share
$0.27
Number of holders
13
Value change
+$390,370
Number of buys
7
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 867781403?
CUSIP 867781403 identifies SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q4 2023

As of 31 Dec 2023, Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,748,847 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, BANK OF AMERICA CORP /DE/, NATIONAL BANK OF CANADA /FI/, and UBS Group AG. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.